You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(1558.HK)漲幅擴大至20% 武漢新型肺炎擴散迅猛
格隆匯 01-20 11:05
格隆匯1月20日丨由於武漢新型肺炎擴散迅猛,東陽光藥(1558.HK)今日暴漲,目前漲幅已擴大至20%,報49.95港元,逼近去年11月創出的歷史最高價50.1港元,最新總市值224億港元。武漢肺炎病例近兩日大增136起,新增死亡病例1例。廣東深圳市確診1例,北京市大興區確診2例患者。這也是武漢新型冠狀病毒肺炎疫情出現以來,國內首次在武漢以外的地區確診這一疾病。東陽光藥是一家專注於抗病毒產品開發、生產及銷售的企業。東陽光藥旗下的“可威”作為該公司抗病毒核心產品之一,也是其最暢銷的產品,受近期流感影響,價格持續上漲。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account